Mannkind (MNKD) traded down -0.31 % during a 24 hours period ending at 03:38 PM Central Europe on Monday 26th. One Mannkind stock can currently be bought for about USD 3.2 on popular exchanges. Current supply of Mannkind stocks is 321.5 mn. Mannkind has a current market capitalization of USD 1 bn and approximately USD 9.9 mn worth of Mannkind was traded on exchanges in the last 24 hours. Since last month end, Mannkind has traded -3.04 % down. Simple moving average of last 200 days is at USD 3.79. The highest price of past 52 weeks was recorded at USD 6.51 on 01/08/2026. 52 weeks low was at USD 2.23 on 03/27/2026.

Here is how related stocks have performed in the past 24 hours:

  • Arizona Sonoran Copper (ASCUF) traded up 5.97 % and now trades at USD 5.82. Current market capitalisation for Arizona Sonoran Copper is USD 1.2 bn.

  • Ambiq Micro (AMBQ) traded up 1.59 % and now trades at USD 50.17. Current market capitalisation for Ambiq Micro is USD 1.2 bn. Ambiq Micro is set to present its latest quarterly results at an upcoming conference on 10 November 2026, covering the period ending 30 September. Analysts anticipate a modest improvement in earnings per share, moving from a larger loss reported in the prior year’s quarter to a smaller loss today. Revenue expectations for the quarter are projected to more than double compared with the same period last year, reflecting significant growth. Looking ahead to the full fiscal year, analysts expect a continued decline in earnings per share, albeit at a less severe level than the previous year’s loss. Revenue guidance for the year is forecast to rise substantially beyond last year’s figures, suggesting expanding business activity. The company’s upcoming report will provide further detail on these developments.

  • Verastem (VSTM) traded down -0.2 % and now trades at USD 9.37. Verastem has a market capitalisation of USD 1.2 bn.

  • Enovis (ENOV) traded down -2.36 % and now trades at USD 20.99. Current market capitalisation for Enovis is USD 1.2 bn.

  • Opko Health (OPK) traded flat 0 % and now trades at USD 1.66. Current market capitalisation for Opko Health is USD 1.2 bn.

About Mannkind

The MannKind Corporation is a biopharmaceutical company that specializes in the development and commercialization of therapeutic products for various diseases such as diabetes, cancer, inflammatory, and autoimmune conditions.